Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

53°
- Newton, NC (28658)
  Today
  
  Abundant sunshine. High 57F. Winds light and variable..
  
  Tonight
  
  Clear skies. Low 26F. Winds light and variable.
  
  Updated: February 13, 2026 @ 12:29 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Classifieds
- Place an ad
e-Edition
Best of 2025
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

46.05 -0.98 (-2.07%)

Streaming Delayed Price Updated: 1:41 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

40 41 Next >

3 Stocks to Buy to Ride Europe’s Coming Market Surge ↗

September 19, 2023

With Europe’s markets looking to perform better in the second half of 2023, here are three European stocks to buy to ride the wave.

Via InvestorPlace

Looking Into Sanofi's Recent Short Interest ↗

September 18, 2023

Via Benzinga

Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs ↗

September 14, 2023

On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,

Via Benzinga

This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now ↗

September 14, 2023

This market is currently in its infancy.

Via The Motley Fool

'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi ↗

September 14, 2023

First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop...

Via Benzinga

(SNY) - Analyzing Sanofi's Short Interest ↗

August 29, 2023

Via Benzinga

2 Top Biotech Stocks to Buy Right Now ↗

August 14, 2023

These drugmakers are among the most dominant in the world.

Via The Motley Fool

Why Shares of MacroGenics Are Jumping Thursday ↗

August 10, 2023

The company announced second-quarter earnings.

Via The Motley Fool

Looking Into Sanofi's Recent Short Interest ↗

August 08, 2023

Via Benzinga

Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm ↗

September 13, 2023

Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.

Via InvestorPlace

Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗

September 13, 2023

Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.

Via Investor's Business Daily

Could This Medicine Be the Next Winner for Novartis? ↗

August 23, 2023

The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials.

Via The Motley Fool

FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth ↗

August 22, 2023

Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth...

Via Benzinga

Is Regeneron Pharmaceuticals Still a Top Growth Stock? ↗

August 21, 2023

The biotech's focus on innovation could be a boon for shareholders.

Via The Motley Fool

The Top Healthcare Stocks to Buy With $100 ↗

July 30, 2023

There's no need to have a fortune to invest in stocks.

Via The Motley Fool

Sanofi (SNY) Q2 2023 Earnings Call Transcript ↗

July 28, 2023

SNY earnings call for the period ending June 30, 2023.

Via The Motley Fool

Sanofi's Earnings Outlook ↗

July 27, 2023

Via Benzinga

2 Biotech Stocks That Could Make You Richer ↗

August 18, 2023

Neither is performing particularly well this year compared to the broader market, but don't let that chase you away.

Via The Motley Fool

Amazon's Boon for Diabetes Patients - Streamlining Pharmacy Discounts ↗

August 15, 2023

Amazon.Com Inc's (NASDAQ: AMZN) online pharmacy launched a new initiativ

Via Benzinga

As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab? ↗

August 08, 2023

Tiziana Life Sciences, Inc.

Via Benzinga

Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon ↗

August 03, 2023

Tiziana Life Sciences (NASDAQ: TLSA), a clinical-stage biotechnology company focused on developing immunotherapies, will soon announce the 6-month results for patients with non-active Secondary...

Via Benzinga

Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

August 01, 2023

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

Via MarketBeat

Topics Artificial Intelligence

iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories ↗

July 28, 2023

Bloomberg

Via Benzinga

Sanofi Reports Lower Q2 Earnings, But Lifts 2023 Outlook On New Drug Launches ↗

July 28, 2023

Sanofi SA (NASDAQ: SNY) reported a 1% decline in Q2 business operating in

Via Benzinga

US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon ↗

July 28, 2023

Stocks appear to have shaken off Thursday's negativity and are positioned for a rebound on upbeat earnings.

Via Benzinga

Enphase Energy, Sanofi, Ford And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

July 28, 2023

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Earnings Scheduled For July 28, 2023 ↗

July 28, 2023

Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is likely to report quarterly earnings at $1.58 per share on revenue of $11.32 billion.

Via Benzinga

Exscientia is the Sniper of the AI Drug Discovery Industry

July 27, 2023

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

Via MarketBeat

Topics Artificial Intelligence

Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports ↗

July 26, 2023

The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication and a weight loss...

Via Benzinga

7 Blue-Chip Stocks That Are Screaming Buys Right Now: July 2023 ↗

July 23, 2023

Even some of the top players of the market don’t get the attention they deserve, making these blue-chip stocks compelling.

Via InvestorPlace

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
e-Edition
Announcements
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Calendar
Email Alerts
Search
Weather

Contact Information

ObserverNewsOnline.com
309 North College Avenue
Newton, NC 28658
Phone: 828-464-0221
Email: admanager@observernewsonline.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Newton, NC (28658)

Today

Tonight

Sanofi - American Depositary Shares (NQ:SNY)

All News about Sanofi - American Depositary Shares

Sections

Services

Contact Information

Follow Us